Changes in CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia

Transplantation

Volumn 85, Issue 12, 2008, Pages 1867-1868

  Fabrizio, Maggi ^a   Valentina, Ricci ^a   Mauro, Bendinelli ^a   Luca, Ceccherini Nelli ^a   Daniele, Focosi ^b   Federico, Papineschi ^b   Mario, Petrini ^b   Elena, Paumgardhen ^c   Massimo, Ghimenti ^c  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; THROMBOCYTE CONCENTRATE; CD57 ANTIGEN; MYELOABLATIVE AGENT;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MULTIPLE MYELOMA; PRIORITY JOURNAL; TORQUE TENO VIRUS; VIREMIA; VIRUS LOAD; VIRUS REACTIVATION; AUTOTRANSPLANTATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; VIRUS INFECTION;

ANTIGENS, CD57; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DNA VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MELPHALAN; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; TORQUE TENO VIRUS; TRANSPLANTATION, AUTOLOGOUS; VIRAL LOAD; VIREMIA;

EID: 49149131195     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817615e6     Document Type: Letter

References (12)

1. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101:2711.
2. Casado J, Soto RD, DelaRosa O, et al. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother 2005; 54: 1162.
3. Sandau M, Winstead C, Jameson S. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J Immunol 2007; 179: 120.
4. Bendinelli M, Maggi F. TT virus and other anelloviruses. In: Mahy B, ter Meulen V, eds. Topley and Wilson-microbiology and microbial infections, Virology volume [10th ed.]. London, England, Arnold E 2005, pp 1276.
5. Okamoto H, Takahashi M, Nishizawa T, et al. Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Commun 2000; 270: 657.
6. Maggi F, Fornai C, Zaccaro L, et al. TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol 2001; 64: 190.
7. Gergely PJ, Perl A, Poor G. Possible pathogenic nature of the recently discovered TT virus: Does it play a role in autoimmune rheumatic diseases? Autoimmun Rev 2006; 6: 5.
8. Maeda M, Hamada H, Tsuda A, et al. High rate of TTV infection in multitransfused patients with pediatric malignancy and hematological disorders. Am JHematol 2000; 65: 41.
9. Garbuglia AR, Iezzi T, Capobianchi MR, et al. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int J Immunopathol Pharmacol 2003; 93: 2485.
10. Kanda Y, Tanaka Y, Kami M, et al. TT virus in bone marrow transplant recipients. Blood 1999; 93: 2485.
11. Frassanito MA, Silvestris F, Cafforio P, et al. CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma. Br J Haematol 1998; 100: 469.
12. Wang EC, Taylor-Wiedeman J, Perera P, et al. Subsets of CD8+, CD57+ cells in normal, healthy individuals: Correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol 1993; 94: 297.